China Financial Media reported that the first Chinese factory of American medical technology company Boston Science Company settled in Shanghai Lingang.
The first news reported on Monday (October 9), and said that Michael Mahoney, the global CEO of Boston Science, attended the signing ceremony in Shanghai on the same day.
Boston Science is one of the main manufacturers of global minimally invasive interventional medical device products. Core products and services include heart intervention, peripheral intervention, endoscopy, urinary and nerve regulation and other fields.In 2022, Boston's global revenue exceeded $ 12 billion (about S $ 16.4 billion).
It is reported that the industry believes that China will become more and more premiere of medical device products.Boston Science will further reduce the production cost of enterprises in China.
However, according to the First Finance, it takes several years from planning to final production from planning to final production.
